摘要
背景:真菌在陆地生态系统与植物正向或负向相互作用中发挥重要作用。这些相互作用是复杂的,并且取决于真菌生活方式,腐烂的,互惠的或致病的,结果是不同的。此外,真菌是众所周知的生产次生代谢产物,来源于不同的生物合成途径,具有相当的生物技术兴趣的生物学特性。在陆地生态系统中,温带森林代表了一个巨大的真菌多样性库。本文将重点介绍森林树木致病和内生真菌产生的次生代谢产物金矿化,重点介绍其生物活性。 方法:使用研究发现应用程序进行结构化的书目数据库搜索,用于同行评议的研究文献,提供访问大量权威的参考资料。选择的论文进行了审查,主要结果进行了报告和讨论。 结果:共收录论文200余篇,概述了病原真菌和嗜血真菌产生的大量次生代谢产物及其生物学活性,包括植物毒性,抗真菌,抗药性,抗菌,致死性致死性,蚊虫叮咬,杀幼虫,细胞毒性,抗增殖和许多其他生物活性。 结论:本研究的结果证实了温带地区生长的森林植物的致病性和内生真菌产生的次生代谢产物对于发现具有新的生物活性和作用方式的化合物具有极好的前景。此外,还强调了一些代谢物作为新药和生物农药的来源的潜力
关键词: 真菌代谢物,抗菌剂,抗癌剂,抗真菌剂,植物毒性剂,动物中毒活性。
Current Medicinal Chemistry
Title:Bioactive Metabolites from Pathogenic and Endophytic Fungi of Forest Trees
Volume: 25 Issue: 2
关键词: 真菌代谢物,抗菌剂,抗癌剂,抗真菌剂,植物毒性剂,动物中毒活性。
摘要: Background: Fungi play an important role in terrestrial ecosystems interacting positively or negatively with plants. These interactions are complex and the outcomes are different depending on the fungal lifestyles, saprotrophic, mutualistic or pathogenic. Furthermore, fungi are well known for producing secondary metabolites, originating from different biosynthetic pathways, which possess biological properties of considerable biotechnological interest. Among the terrestrial ecosystems, temperate forests represent an enormous reservoir of fungal diversity. This review will highlight the goldmine of secondary metabolites produced by pathogenic and endophytic fungi of forest trees with focus on their biological activities.
Methods: A structured search of bibliographic databases for peer-reviewed research literature was undertaken using a research discovery application providing access to a large and authoritative source of references. The papers selected were examined and the main results were reported and discussed.
Results: Two hundred forthy-one papers were included in the review, outlined a large number of secondary metabolites produced by pathogenic and endophiltic fungi and their biological activities, including phytotoxic, antifungal, antioomycetes, antibacterial, brine shrimp lethality, mosquito biting deterrence and larvicidal, cytotoxic, antiproliferative and many other bioactivities.
Conclusion: The findings of this review confirm the importance of secondary metabolites produced by pathogenic and endophytic fungi from forest plants growing in temperate regions as an excellent prospects to discover compounds with new bioactivities and mode of actions. In addition, the potential of some metabolites as a source of new drugs and biopesticides is underlined.
Export Options
About this article
Cite this article as:
Bioactive Metabolites from Pathogenic and Endophytic Fungi of Forest Trees, Current Medicinal Chemistry 2018; 25 (2) . https://dx.doi.org/10.2174/0929867324666170314145159
DOI https://dx.doi.org/10.2174/0929867324666170314145159 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Overview of Mechanisms of Cancer Stem Cell Drug Resistance
Current Signal Transduction Therapy Current Issues in the Utility of Blood Oxygen Level Dependent MRI for the Assessment of Modulations in Tumor Oxygenation
Current Medical Imaging To Be-et, or Not to Be-et, That is the Question: The Role(s) of Nitrate and Nitrite in Health and Illness
Reviews on Recent Clinical Trials Matrix Metalloproteinase Inhibitors as Prospective Agents for the Prevention and Treatment of Cardiovascular and Neoplastic Diseases
Current Topics in Medicinal Chemistry Gene Therapy for Gastric Diseases
Current Gene Therapy Chloride Channel Expression and Functional Diversity in the Immune Cells of Allergic Diseases
Current Molecular Medicine Pathogenic Mechanisms and Therapeutic Strategies in Spinobulbar Muscular Atrophy
CNS & Neurological Disorders - Drug Targets Application of Carbon Nanotubes In Drug Delivery of Non-cancerous Diseases: A Review
Current Pharmaceutical Design The Impact of Docosahexaenoic Acid on Alzheimer’s Disease: Is There a Role of the Blood-Brain Barrier?
Current Clinical Pharmacology Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer
Clinical Cancer Drugs Brain Permeable Nanoparticles
Recent Patents on CNS Drug Discovery (Discontinued) Mesenchymal Stem/Stromal Cells: A New "Cells as Drugs" Paradigm. Efficacy and Critical Aspects in Cell Therapy
Current Pharmaceutical Design Editorial [Hot Topic: SOD Enzymes and Their Mimics in Cancer:Pro- vs Anti-Oxidative Mode of Action-Part II (Guest Editor: Ines Batinic-Haberle)]
Anti-Cancer Agents in Medicinal Chemistry From Nucleic Acids to Drug Discovery: Nucleobases as Emerging Templates for Drug Candidates
Current Medicinal Chemistry Recent Development in Fluorescent Probes for Copper Ion Detection
Current Topics in Medicinal Chemistry An Update of the Classical and Novel Methods Used for Measuring Fast Neurotransmitters During Normal and Brain Altered Function
Current Neuropharmacology Polyphenols and Neuroprotection against Ischemia and Neurodegeneration
Mini-Reviews in Medicinal Chemistry The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters
Anti-Cancer Agents in Medicinal Chemistry Decoding the Knots of Initiation of Oncogenic Epithelial-Mesenchymal Transition in Tumor Progression
Current Cancer Drug Targets Translational Multimodality Neuroimaging
Current Drug Targets